Purchase Order 75N94023P00641
Award Date
8/10/23
Potential Completion Date
12/7/23
Potential Value
$13K
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
NAICS Category
339112 - Surgical and Medical Instrument Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for $19,614.63 to provide "GENOMIC EDITING SERVICE KNOCK-OUT" services to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services. The contract is a firm fixed-price purchase order with a completion date of September 29, 2023. Genscript, which is not a small business, has received...
This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $15,289.00 contract will run through September 30, 2024 and does not have a set-aside designation. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services that support...
This federal contract award, valued at $24,999.00, was issued by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company based in New Jersey. The contract requires Genscript to generate four stable cell lines, with a final completion date of March 11, 2022. This was a firm fixed-price purchase order, and there was no set-aside designation. Genscript has received...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a small business biotechnology company based in Piscataway, New Jersey, for $11,434.95. The contract has an ultimate completion date of July 30, 2025. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other...
This is a federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at up to $11,500.00, was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services (HHS). The contract is a Blanket Purchase Agreement (BPA) call order, with a firm fixed-price pricing type. Through this contract, Genscript provides a wide range of molecular biology...
This $12,922.70 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH), to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The award is for the provision of various laboratory equipment and accessories, including thermostats, centrifuges, and rotors. While the contract has no set-aside...
This firm fixed-price purchase order for $18,204.88 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Genscript USA Inc. to obtain cell lines utilizing CRISPR gene editing technology. Specifically, the contract calls for Genscript to generate knockout HEK293 and HepG2 cell lines of the MMAB and MUT genes to support studies for hereditary disorders of vitamin B12 and methylmalonic acid metabolism. No set-aside designation...
This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, was issued by the National Cancer Institute, a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The $4,217.03 firm fixed-price delivery order is for peptide services and does not have a set-aside designation. Genscript is a major provider of molecular biology products and services to federal agencies, including the NIH, Centers...
This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National...